Massy ZA - Search Results

1

Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease.

Hamza E, Vallejo-Mudarra M, Ouled-Haddou H, García-Caballero C, Guerrero-Hue M, Santier L, Rayego-Mateos S, Larabi IA, Alvarez JC, Garçon L, Massy ZA, Choukroun G, Moreno JA, Metzinger L, Meuth VM. Hamza E, et al. Among authors: massy za. Cell Signal. 2023 Apr;104:110583. doi: 10.1016/j.cellsig.2022.110583. Epub 2022 Dec 31. Cell Signal. 2023. PMID: 36596353

2

Atherosclerotic complications in chronic renal failure: epidemiology and predictive factors.

Jungers P, Nguyen Khoa T, Joly D, Choukroun G, Witko-Sarsat V, Massy ZA. Jungers P, et al. Among authors: massy za. Adv Nephrol Necker Hosp. 2000;30:177-99. Adv Nephrol Necker Hosp. 2000. PMID: 11068642 Review. No abstract available.

3

Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998.

Jungers P, Choukroun G, Robino C, Massy ZA, Taupin P, Labrunie M, Man NK, Landais P. Jungers P, et al. Among authors: massy za. Nephrol Dial Transplant. 2000 Dec;15(12):2000-6. doi: 10.1093/ndt/15.12.2000. Nephrol Dial Transplant. 2000. PMID: 11096146

4

Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients.

Jungers PY, Robino C, Choukroun G, Nguyen-Khoa T, Massy ZA, Jungers P. Jungers PY, et al. Among authors: massy za. Nephrol Dial Transplant. 2002 Sep;17(9):1621-7. doi: 10.1093/ndt/17.9.1621. Nephrol Dial Transplant. 2002. PMID: 12198213

5

[Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].

Jungers PY, Nguyen-Khoa T, Joly D, Choukroun G, Massy ZA, Jungers P. Jungers PY, et al. Among authors: massy za. Presse Med. 2003 Feb 8;32(5):212-6. Presse Med. 2003. PMID: 12610461 French.

6

[Management of micro-inflammation in uremia].

Massy ZA, Choukroun G. Massy ZA, et al. Nephrologie. 2003;24(7):415-7. Nephrologie. 2003. PMID: 14650756 Review. French.

7

Impact of inflammation and oxidative stress on vascular calcifications in chronic kidney disease.

Massy ZA, Mazière C, Kamel S, Brazier M, Choukroun G, Tribouilloy C, Slama M, Andrejak M, Mazière JC. Massy ZA, et al. Pediatr Nephrol. 2005 Mar;20(3):380-2. doi: 10.1007/s00467-004-1623-9. Epub 2004 Nov 10. Pediatr Nephrol. 2005. PMID: 15549414 Review.

8

Drug Insight: renal indications of calcimimetics.

Shahapuni I, Monge M, Oprisiu R, Mazouz H, Westeel PF, Morinière P, Massy Z, Choukroun G, Fournier A. Shahapuni I, et al. Nat Clin Pract Nephrol. 2006 Jun;2(6):316-25. doi: 10.1038/ncpneph0191. Nat Clin Pract Nephrol. 2006. PMID: 16932453 Review.

9

Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.

Monge M, Shahapuni I, Oprisiu R, El Esper N, Morinière P, Massy Z, Choukroun G, Fournier A. Monge M, et al. Nat Clin Pract Nephrol. 2006 Jun;2(6):326-36. doi: 10.1038/ncpneph0189. Nat Clin Pract Nephrol. 2006. PMID: 16932454

10

[Which optimal antihypertensive bitherapy for kidney patients?].

Bonne JF, Shahapuni I, Mailliez S, Oprisiu R, Temmar M, Choukroun G, Massy ZA, Fournier A. Bonne JF, et al. Among authors: massy za. Nephrol Ther. 2007 Jun;3(3):79-88. doi: 10.1016/j.nephro.2007.03.002. Epub 2007 May 8. Nephrol Ther. 2007. PMID: 17540309 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

516 results

Search Page